Prognostic value of inflammation-based markers in limited disease small-cell lung cancer (LD-SCLC)

被引：0
|
作者：
Kaesmann, L. [1 ]
Bolm, L. [1 ]
Janssen, S. [1 ]
Rades, D. [1 ]
机构：
[1] Univ Lubeck, Dept Radiat Oncol, Lubeck, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2017年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V18-3-jD
引用
收藏
页码：S53 / S54
页数：2
相关论文
共 50 条
  • [1] Associations between Comorbidity, Treatment Toxicity and Overall Survival in Limited Disease Small-Cell Lung Cancer (LD-SCLC)
    Gronberg, Bjorn H.
    Sundstrom, Stein H.
    Flotten, Oystein
    Brustugun, Odd Terje
    Brunsvig, Paal F.
    Bremnes, Roy M.
    Kaasa, Stein
    Halvorsen, Tarje O.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S744 - S744
  • [2] External Validation of a Survival Score for Limited Disease Small Cell Lung Cancer (LD-SCLC)
    Kaesmann, L.
    Abdo, R.
    Eze, C.
    Dantes, M.
    Taugner, J.
    Gennen, K.
    Roengvoraphoj, O.
    Rades, D.
    Niyazi, M.
    Belka, C.
    Manapov, F.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S750 - S750
  • [3] External validation of a survival score for limited disease small cell lung cancer (LD-SCLC)
    Abdo, R.
    L, Kaesmann
    Eze, C.
    Dantes, M.
    Roengvoraphoj, O.
    Taugner, J.
    Petrukhnov, O.
    Rades, D.
    Manapov, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 : S137 - S137
  • [4] Prophylactic cranial irradiation (PCI) in limited-disease small-cell lung cancer (LD-SCLC) patients with brain imaging
    Mamesaya, Nobuaki
    Wakuda, Kazushige
    Kotake, Mie
    Fujiwara, Takumi
    Kobayashi, Haruki
    Kawamura, Takahisa
    Nakashima, Kazuhisa
    Omori, Shota
    Ono, Akira
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] PATTERNS OF FAILURE AFTER COMBINED TREATMENT OF LIMITED DISEASE - SMALL CELL LUNG CANCER (LD-SCLC)
    Wierzchowski, M.
    Sprawka, A.
    Kepka, L.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S287 - S287
  • [6] Clinical outcome of chemoradiotherapy in patients (pts) with limited-disease small-cell lung cancer (LD-SCLC) with ipsilateral pleural effusion
    Niho, S.
    Kubota, K.
    Yoh, K.
    Goto, K.
    Ohmatsu, H.
    Saijo, N.
    Nishiwaki, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Isolated nodal failure after chemo-radiotherapy in limited disease small cell lung cancer (LD-SCLC)
    Wierzchowski, Marek
    Sprawka, Arkadiusz
    Kepka, Lucyna
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2009, 14 (02) : 58 - 63
  • [8] Is the total dose of importance in thoracic radiotherapy of small-cell lung cancer (SCLC) limited disease (LD)?
    Hallqvist, A
    Nyman, J
    Rylander, H
    LUNG CANCER, 2005, 49 : S320 - S321
  • [9] Detection of unsuspected distant metastases and/or regional nodes by FDG-PET in LD-SCLC scan in apparent limited-disease small-cell lung cancer
    Niho, Seiji
    Fujii, Hirofumi
    Murakami, Koji
    Nagase, Seisuke
    Yoh, Kiyotaka
    Goto, Koichi
    Ohmatsu, Hironobu
    Kubota, Kaoru
    Sekiguchi, Ryuzo
    Nawano, Shigeru
    Saijo, Nagahiro
    Nishiwaki, Yutaka
    LUNG CANCER, 2007, 57 (03) : 328 - 333
  • [10] The results of combined modality therapy for limited stage small cell lung cancer (LD-SCLC) in the elderly.
    Schild, SE
    Stella, PJ
    Brooks, BJ
    Mandrekar, S
    Bonner, JA
    McGinnis, WL
    Nikcevich, DA
    Adjei, AA
    Jatoi, A
    Jett, JR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 627S - 627S
12345